Probi AB (publ) (PROB.ST)
SEK 347.0
(-0.29%)
SEK 347.0
(-0.29%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 1.48 SEK | -58.54% |
| 2022 | 3.57 SEK | -51.1% |
| 2021 | 7.30 SEK | -10.32% |
| 2020 | 8.14 SEK | 7.96% |
| 2019 | 7.54 SEK | 12.71% |
| 2018 | 6.69 SEK | 10.4% |
| 2017 | 6.06 SEK | -43.52% |
| 2016 | 10.73 SEK | 111.22% |
| 2015 | 5.08 SEK | 125.78% |
| 2014 | 2.25 SEK | 44.23% |
| 2013 | 1.56 SEK | 11.43% |
| 2012 | 1.40 SEK | -3.45% |
| 2011 | 1.45 SEK | 5.07% |
| 2010 | 1.38 SEK | 26.61% |
| 2009 | 1.09 SEK | 36.25% |
| 2008 | 0.80 SEK | -67.61% |
| 2007 | 2.47 SEK | 604.08% |
| 2006 | -0.49 SEK | -155.06% |
| 2005 | 0.89 SEK | 32.84% |
| 2004 | 0.67 SEK | 252.63% |
| 2003 | 0.19 SEK | -40.63% |
| 2002 | 0.32 SEK | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q3 | 0.31 SEK | -56.34% |
| 2024 Q1 | 0.16 SEK | 169.57% |
| 2024 Q2 | 0.71 SEK | 343.75% |
| 2023 Q3 | 0.56 SEK | 201.82% |
| 2023 Q2 | -0.55 SEK | -132.54% |
| 2023 Q4 | -0.23 SEK | -141.07% |
| 2023 Q1 | 1.69 SEK | 438.0% |
| 2023 FY | - SEK | -58.54% |
| 2022 Q3 | 1.09 SEK | -37.71% |
| 2022 Q2 | 1.75 SEK | 42.28% |
| 2022 FY | - SEK | -51.1% |
| 2022 Q4 | -0.50 SEK | -145.87% |
| 2022 Q1 | 1.23 SEK | -46.75% |
| 2021 Q4 | 2.31 SEK | 42.59% |
| 2021 Q1 | 1.99 SEK | 3.65% |
| 2021 Q2 | 1.39 SEK | -30.15% |
| 2021 Q3 | 1.62 SEK | 16.55% |
| 2021 FY | - SEK | -10.32% |
| 2020 Q3 | 2.91 SEK | 22.78% |
| 2020 Q2 | 2.37 SEK | 152.13% |
| 2020 FY | - SEK | 7.96% |
| 2020 Q1 | 0.94 SEK | -58.59% |
| 2020 Q4 | 1.92 SEK | -34.02% |
| 2019 Q2 | 2.62 SEK | 249.33% |
| 2019 Q1 | 0.75 SEK | -64.29% |
| 2019 Q3 | 1.90 SEK | -27.48% |
| 2019 Q4 | 2.27 SEK | 19.47% |
| 2019 FY | - SEK | 12.71% |
| 2018 Q3 | 2.47 SEK | 34.24% |
| 2018 Q1 | 0.29 SEK | 244.01% |
| 2018 FY | - SEK | 10.4% |
| 2018 Q4 | 2.10 SEK | -14.98% |
| 2018 Q2 | 1.84 SEK | 534.48% |
| 2017 Q3 | 0.77 SEK | -45.77% |
| 2017 Q2 | 1.42 SEK | -62.53% |
| 2017 Q1 | 3.79 SEK | -0.52% |
| 2017 Q4 | 0.08 SEK | -89.05% |
| 2017 FY | - SEK | -43.52% |
| 2016 Q3 | 2.87 SEK | 63.07% |
| 2016 Q1 | 2.78 SEK | 892.86% |
| 2016 FY | - SEK | 111.22% |
| 2016 Q4 | 3.81 SEK | 32.75% |
| 2016 Q2 | 1.76 SEK | -36.69% |
| 2015 Q3 | 1.36 SEK | 21.43% |
| 2015 Q2 | 1.12 SEK | -51.52% |
| 2015 Q4 | 0.28 SEK | -79.41% |
| 2015 FY | - SEK | 125.78% |
| 2015 Q1 | 2.31 SEK | 312.5% |
| 2014 Q4 | 0.56 SEK | -23.29% |
| 2014 FY | - SEK | 44.23% |
| 2014 Q3 | 0.73 SEK | 65.91% |
| 2014 Q2 | 0.44 SEK | -15.38% |
| 2014 Q1 | 0.52 SEK | 92.59% |
| 2013 Q2 | 0.40 SEK | -21.57% |
| 2013 Q1 | 0.51 SEK | 131.82% |
| 2013 FY | - SEK | 11.43% |
| 2013 Q4 | 0.27 SEK | -30.77% |
| 2013 Q3 | 0.39 SEK | -2.5% |
| 2012 Q3 | 0.30 SEK | 42.86% |
| 2012 FY | - SEK | -3.45% |
| 2012 Q1 | 0.67 SEK | 2220.25% |
| 2012 Q2 | 0.21 SEK | -68.66% |
| 2012 Q4 | 0.22 SEK | -26.67% |
| 2011 Q2 | 0.50 SEK | -3.85% |
| 2011 Q3 | 0.46 SEK | -8.0% |
| 2011 Q4 | -0.03 SEK | -106.87% |
| 2011 FY | - SEK | 5.07% |
| 2011 Q1 | 0.52 SEK | 116.67% |
| 2010 Q1 | 0.25 SEK | 0.0% |
| 2010 FY | - SEK | 26.61% |
| 2010 Q3 | 0.68 SEK | 209.09% |
| 2010 Q4 | 0.24 SEK | -64.71% |
| 2010 Q2 | 0.22 SEK | -12.0% |
| 2009 FY | - SEK | 36.25% |
| 2008 FY | - SEK | -67.61% |
| 2007 FY | - SEK | 604.08% |
| 2006 FY | - SEK | -155.06% |
| 2005 FY | - SEK | 32.84% |
| 2004 FY | - SEK | 252.63% |
| 2003 FY | - SEK | -40.63% |
| 2002 FY | - SEK | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| AcuCort AB | -0.16 SEK | 1025.0% |
| AlzeCure Pharma AB (publ) | -0.60 SEK | 346.667% |
| BioGaia AB (publ) | 3.62 SEK | 59.116% |
| Enzymatica AB (publ) | -0.28 SEK | 628.571% |
| Enorama Pharma AB (publ) | -1.61 SEK | 191.925% |
| Gabather AB (publ) | -0.65 SEK | 327.692% |
| Klaria Pharma Holding AB (publ.) | -0.36 SEK | 511.111% |
| Moberg Pharma AB (publ) | -1.33 SEK | 211.278% |
| Nanexa AB (publ) | -1.09 SEK | 235.78% |
| Newbury Pharmaceuticals AB (publ) | -0.72 SEK | 305.556% |
| ODI Pharma AB | 0.02 SEK | -6224.786% |
| Orexo AB (publ) | -3.73 SEK | 139.678% |
| Swedencare AB (publ) | 0.37 SEK | -300.0% |
| Swedish Orphan Biovitrum AB (publ) | 7.47 SEK | 80.187% |
| Toleranzia AB | -0.06 SEK | 2742.857% |
| Vivesto AB | -0.74 SEK | 300.0% |